Kidney Health: Eat Well, Live Well

Inclusion Criteria: Adult (18 years of age or older) Primary care patient at either one of the three partner clinics from Harris Health [Smith Clinic, Harris Health Outpatient Center (located on the LBJ campus), or Martin Luther King Jr. Health Center (MLK)] Have had at least 1 visit in the past 18 months with prior history in the clinic (i.e., not first visit) Diagnosis of CKD (Stage 2, 3a, and 3b) as defined by estimated Glomerular Filtration Rate (eGFR) ≥ 30 and <90 mL/min/1.73 m2 *OR* CDK stage 1 (diagnosed or not) with urine Albumin Creatinine Ratio ≥ 30 mg/g Within the past 12 months, the most current serum K+ ≤ 4.6 mEq/L If prescribed, on maximum dose and adherent to ACE or ARB medication for at least 4 weeks before enrolment (visit 1) English or Spanish speaking Ability to participate in the program at least 6 months Ability to clean, prepare, refrigerate/freeze food products that are given to them Have access to receive SMS text messages Location of preferred produce bag delivery within an available delivery zone Exclusion Criteria: CKD 4, ESRD or on dialysis. Taking certain medications chronically (more than twice a week for 90 days) that may interfere with K+ metabolism (such as non-steroidal anti-inflammatory drugs (NSAIDs) Taking mineralocorticoid receptor antagonists Taking Warfarin Diagnosis of any specific kidney conditions (such as polycystic kidney disease, glomerulonephritis, Lupus associated with Nephritis, Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)) that would contraindicate study participation as determined by physician Medical history of organ transplant that would contraindicate study participation as determined by physician Received immunotherapy for primary or secondary kidney disease within 6 months prior to enrolment Diagnostic of heart failure conditions Class IV in the New York Heart Association (NYHA) functional classification Diagnosis of diabetes mellitus type 1 Had myocardial infarction, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks prior to enrolment that would contraindicate study participation as determined by physician Had coronary revascularization (PCI, CABG) or valvular repair within 12 weeks prior to enrolment Life expectancy is less than 2 years, such as in the case of certain medical conditions as determined by physician Diagnosis of active malignancy requiring treatment that would contraindicate study participation as determined by physician Has decompensated cirrhosis Cognitive impairment that would contraindicate study participation as determined by physician